FDA inspection
Vaughn, Silverberg and Associates, LLP: FDA inspection ending Oct 7, 2008
FDA inspection 541693 · No Action Indicated (NAI) · Austin, TX
Key facts
| Inspection ID | 541693 |
|---|---|
| Firm | Vaughn, Silverberg and Associates, LLP |
| FEI number | 3003724356 |
| Address | 6500 N Mopac Expressway, Building 1, Suite 1200 |
| City | Austin |
| State | TX |
| ZIP | 78731 |
| Country | United States |
| Fiscal year | 2009 |
| Inspection end date | Oct 7, 2008 |
| Classification | No Action Indicated (NAI) |
| Project area | Human Cellular, Tissue, and Gene Therapies |
| Product type | Biologics |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data